Medplus Health Services Limited has informed the Exchange regarding 'Disclosure under Regulation 31 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011'.
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Promoter Agilemed Investments Private Limited has released (unpledged) 41,71,970 equity shares of Medplus Health Services, equivalent to 3.48% of the company's total share capital, with a value of approximately ₹342.23 crore based on the closing price of ₹820.30 on December 24, 2025. The release was done in favour of Debenture Trustee Catalyst Trusteeship Limited (for lender Modulus Alternatives) following the repayment of existing debt as part of a refinancing of non-convertible debentures. After this release, the aggregate promoter group pledge has come down to 24.48% of total share capital (from a temporary peak of 27.96% during the refinancing). Total promoter shareholding remains at 40.29% of the company, of which 60.74% (about 2.93 crore shares) is still encumbered.
This is a positive signal for shareholders — the unpledging of shares reduces the risk of a forced sale or margin call, and reflects that the promoter group has successfully refinanced and partially retired debt. However, a significant portion of promoter shares (about 24.48% of total capital) remains pledged, which is still a noteworthy risk factor to monitor.